WO2001016305A2 - Nucleotide sequences encoding an insectidal protein complex from serratia - Google Patents
Nucleotide sequences encoding an insectidal protein complex from serratia Download PDFInfo
- Publication number
- WO2001016305A2 WO2001016305A2 PCT/NZ2000/000174 NZ0000174W WO0116305A2 WO 2001016305 A2 WO2001016305 A2 WO 2001016305A2 NZ 0000174 W NZ0000174 W NZ 0000174W WO 0116305 A2 WO0116305 A2 WO 0116305A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- insecticidal
- nucleic acid
- seq
- acid molecule
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 121
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 71
- 108091028043 Nucleic acid sequence Proteins 0.000 title claims abstract description 27
- 241000607720 Serratia Species 0.000 title abstract description 9
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 81
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 71
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 71
- 230000000749 insecticidal effect Effects 0.000 claims abstract description 57
- 239000012634 fragment Substances 0.000 claims abstract description 55
- 201000010099 disease Diseases 0.000 claims abstract description 42
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 42
- 230000035772 mutation Effects 0.000 claims abstract description 42
- 239000002773 nucleotide Substances 0.000 claims abstract description 35
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 35
- 241000238631 Hexapoda Species 0.000 claims abstract description 31
- 241000500845 Costelytra zealandica Species 0.000 claims abstract description 21
- 241000196324 Embryophyta Species 0.000 claims abstract description 15
- 230000007935 neutral effect Effects 0.000 claims abstract description 15
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 9
- 241001135258 Serratia proteamaculans Species 0.000 claims abstract description 6
- 241000147799 Serratia entomophila Species 0.000 claims abstract description 5
- 239000000575 pesticide Substances 0.000 claims abstract description 4
- 241000254062 Scarabaeidae Species 0.000 claims abstract description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 83
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 72
- 229920001184 polypeptide Polymers 0.000 claims description 70
- 108700012359 toxins Proteins 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 43
- 239000013612 plasmid Substances 0.000 claims description 43
- 239000003053 toxin Substances 0.000 claims description 43
- 231100000765 toxin Toxicity 0.000 claims description 43
- 239000013598 vector Substances 0.000 claims description 40
- 108020004414 DNA Proteins 0.000 claims description 38
- 230000014509 gene expression Effects 0.000 claims description 22
- 241000894006 Bacteria Species 0.000 claims description 21
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 15
- 239000000523 sample Substances 0.000 claims description 15
- 239000013604 expression vector Substances 0.000 claims description 12
- 241000700605 Viruses Species 0.000 claims description 10
- 150000001413 amino acids Chemical class 0.000 claims description 10
- 230000009261 transgenic effect Effects 0.000 claims description 9
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 8
- 239000003446 ligand Substances 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 7
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 6
- 108700003918 Bacillus Thuringiensis insecticidal crystal Proteins 0.000 claims description 6
- 108010089254 Cholesterol oxidase Proteins 0.000 claims description 6
- 241000193403 Clostridium Species 0.000 claims description 6
- 239000000891 luminescent agent Substances 0.000 claims description 6
- 230000002231 mosquitocidal effect Effects 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 241000254173 Coleoptera Species 0.000 claims description 5
- 230000001939 inductive effect Effects 0.000 claims description 5
- 238000003259 recombinant expression Methods 0.000 claims description 5
- 239000002299 complementary DNA Substances 0.000 claims description 4
- 230000009466 transformation Effects 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 241000607714 Serratia sp. Species 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 230000000855 fungicidal effect Effects 0.000 claims description 2
- 230000002363 herbicidal effect Effects 0.000 claims description 2
- 239000002917 insecticide Substances 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 230000001069 nematicidal effect Effects 0.000 claims description 2
- 239000002689 soil Substances 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 238000001890 transfection Methods 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 abstract description 24
- 238000009396 hybridization Methods 0.000 abstract description 11
- 241000588921 Enterobacteriaceae Species 0.000 abstract description 3
- 235000018102 proteins Nutrition 0.000 description 61
- 210000004027 cell Anatomy 0.000 description 31
- 241000588724 Escherichia coli Species 0.000 description 26
- 101100371219 Pseudomonas putida (strain DOT-T1E) ttgE gene Proteins 0.000 description 20
- 238000003780 insertion Methods 0.000 description 20
- 230000037431 insertion Effects 0.000 description 20
- 230000007918 pathogenicity Effects 0.000 description 20
- 241001148064 Photorhabdus luminescens Species 0.000 description 19
- 238000012217 deletion Methods 0.000 description 15
- 230000037430 deletion Effects 0.000 description 15
- 125000000539 amino acid group Chemical group 0.000 description 13
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 12
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 12
- 108091008146 restriction endonucleases Proteins 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 11
- 101100371218 Pseudomonas putida (strain DOT-T1E) ttgD gene Proteins 0.000 description 10
- 230000000295 complement effect Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 101150085300 sepA gene Proteins 0.000 description 10
- 101100365469 Pseudomonas putida (strain ATCC 700007 / DSM 6899 / BCRC 17059 / F1) sepB gene Proteins 0.000 description 9
- 230000001887 anti-feedant effect Effects 0.000 description 9
- 238000004166 bioassay Methods 0.000 description 8
- 210000002421 cell wall Anatomy 0.000 description 8
- 102100031725 Cortactin-binding protein 2 Human genes 0.000 description 7
- 101710197985 Probable protein Rev Proteins 0.000 description 7
- 101100042278 Pseudomonas putida (strain ATCC 700007 / DSM 6899 / BCRC 17059 / F1) sepC gene Proteins 0.000 description 7
- 101100371220 Pseudomonas putida (strain DOT-T1E) ttgF gene Proteins 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 235000014469 Bacillus subtilis Nutrition 0.000 description 6
- 244000000626 Daucus carota Species 0.000 description 6
- 235000002767 Daucus carota Nutrition 0.000 description 6
- 241000607142 Salmonella Species 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- 229960005091 chloramphenicol Drugs 0.000 description 6
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 6
- 238000002703 mutagenesis Methods 0.000 description 6
- 231100000350 mutagenesis Toxicity 0.000 description 6
- 238000003752 polymerase chain reaction Methods 0.000 description 6
- 241001515965 unidentified phage Species 0.000 description 6
- 101000621943 Acholeplasma phage L2 Probable integrase/recombinase Proteins 0.000 description 5
- 101000618348 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) Uncharacterized protein Alvin_0065 Proteins 0.000 description 5
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical group NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 5
- 101000781117 Autographa californica nuclear polyhedrosis virus Uncharacterized 12.4 kDa protein in CTL-LEF2 intergenic region Proteins 0.000 description 5
- 101000708323 Azospirillum brasilense Uncharacterized 28.8 kDa protein in nifR3-like 5'region Proteins 0.000 description 5
- 101000770311 Azotobacter chroococcum mcd 1 Uncharacterized 19.8 kDa protein in nifW 5'region Proteins 0.000 description 5
- 101000748761 Bacillus subtilis (strain 168) Uncharacterized MFS-type transporter YcxA Proteins 0.000 description 5
- 101000765620 Bacillus subtilis (strain 168) Uncharacterized protein YlxP Proteins 0.000 description 5
- 101000916134 Bacillus subtilis (strain 168) Uncharacterized protein YqxJ Proteins 0.000 description 5
- 101000754349 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) UPF0065 protein BP0148 Proteins 0.000 description 5
- 101000827633 Caldicellulosiruptor sp. (strain Rt8B.4) Uncharacterized 23.9 kDa protein in xynA 3'region Proteins 0.000 description 5
- 101000947628 Claviceps purpurea Uncharacterized 11.8 kDa protein Proteins 0.000 description 5
- 101000686796 Clostridium perfringens Replication protein Proteins 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 5
- 101000788129 Escherichia coli Uncharacterized protein in sul1 3'region Proteins 0.000 description 5
- 101000788370 Escherichia phage P2 Uncharacterized 12.9 kDa protein in GpA 3'region Proteins 0.000 description 5
- 101000787096 Geobacillus stearothermophilus Uncharacterized protein in gldA 3'region Proteins 0.000 description 5
- 101000976889 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 19.2 kDa protein in cox-rep intergenic region Proteins 0.000 description 5
- 101000827627 Klebsiella pneumoniae Putative low molecular weight protein-tyrosine-phosphatase Proteins 0.000 description 5
- 101001130841 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF5 Proteins 0.000 description 5
- 101000974028 Rhizobium leguminosarum bv. viciae (strain 3841) Putative cystathionine beta-lyase Proteins 0.000 description 5
- 101000756519 Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) Uncharacterized protein RCAP_rcc00048 Proteins 0.000 description 5
- 101000948219 Rhodococcus erythropolis Uncharacterized 11.5 kDa protein in thcD 3'region Proteins 0.000 description 5
- 238000012300 Sequence Analysis Methods 0.000 description 5
- 101000936711 Streptococcus gordonii Accessory secretory protein Asp4 Proteins 0.000 description 5
- 101000929863 Streptomyces cinnamonensis Monensin polyketide synthase putative ketoacyl reductase Proteins 0.000 description 5
- 101000788468 Streptomyces coelicolor Uncharacterized protein in mprR 3'region Proteins 0.000 description 5
- 101000845085 Streptomyces violaceoruber Granaticin polyketide synthase putative ketoacyl reductase 1 Proteins 0.000 description 5
- 101000711771 Thiocystis violacea Uncharacterized 76.5 kDa protein in phbC 3'region Proteins 0.000 description 5
- 101000711318 Vibrio alginolyticus Uncharacterized 11.6 kDa protein in scrR 3'region Proteins 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 230000010076 replication Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- -1 (for example Proteins 0.000 description 4
- 101710087110 ORF6 protein Proteins 0.000 description 4
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 4
- 101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 description 4
- 101710144099 Wall-associated protein Proteins 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 230000004313 glare Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 230000006337 proteolytic cleavage Effects 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 102000008579 Transposases Human genes 0.000 description 3
- 108010020764 Transposases Proteins 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 2
- 101100437895 Alternaria brassicicola bsc3 gene Proteins 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical compound OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 241000238657 Blattella germanica Species 0.000 description 2
- 241000588832 Bordetella pertussis Species 0.000 description 2
- 108010090591 Cloacin Proteins 0.000 description 2
- 241000193163 Clostridioides difficile Species 0.000 description 2
- 241001635274 Cydia pomonella Species 0.000 description 2
- 241000709823 Dictyoptera <beetle genus> Species 0.000 description 2
- 102100035261 FYN-binding protein 1 Human genes 0.000 description 2
- 108091011190 FYN-binding protein 1 Proteins 0.000 description 2
- 241000255777 Lepidoptera Species 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- 108050004278 Mosquitocidal toxin Proteins 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- 101150073872 ORF3 gene Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 241000532856 Otiorhynchus sulcatus Species 0.000 description 2
- 241000193157 Paraclostridium bifermentans Species 0.000 description 2
- 101100226891 Phomopsis amygdali PaP450-1 gene Proteins 0.000 description 2
- 241001148062 Photorhabdus Species 0.000 description 2
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 2
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 108700005075 Regulator Genes Proteins 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 101710117021 Tyrosine-protein phosphatase YopH Proteins 0.000 description 2
- 241001415096 Vespula germanica Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 238000012505 colouration Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 239000003228 hemolysin Substances 0.000 description 2
- 230000001418 larval effect Effects 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 101150079601 recA gene Proteins 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 101150084425 spvB gene Proteins 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 241001229759 Acrossidius tasmaniae Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- YNCHFVRXEQFPBY-BQBZGAKWSA-N Asp-Gly-Arg Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N YNCHFVRXEQFPBY-BQBZGAKWSA-N 0.000 description 1
- 241000701897 Bacillus virus B103 Species 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 241000238662 Blatta orientalis Species 0.000 description 1
- RZZPDXZPRHQOCG-OJAKKHQRSA-O CDP-choline(1+) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-O 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010073254 Colicins Proteins 0.000 description 1
- 241000272203 Columba Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241001509964 Coptotermes Species 0.000 description 1
- 241001445332 Coxiella <snail> Species 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 101710150441 DNA-invertase Proteins 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241001131785 Escherichia coli HB101 Species 0.000 description 1
- 101000578492 Escherichia coli Lysis protein Proteins 0.000 description 1
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241001147381 Helicoverpa armigera Species 0.000 description 1
- 241000255967 Helicoverpa zea Species 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- 241001176496 Heteronychus arator Species 0.000 description 1
- 241001387505 Heterotermes tenuis Species 0.000 description 1
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 1
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 1
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 102100024407 Jouberin Human genes 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 241000254022 Locusta migratoria Species 0.000 description 1
- 241000920471 Lucilia caesar Species 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 241000255908 Manduca sexta Species 0.000 description 1
- 241000257159 Musca domestica Species 0.000 description 1
- 241000721621 Myzus persicae Species 0.000 description 1
- 241001671709 Nezara viridula Species 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 101710116435 Outer membrane protein Proteins 0.000 description 1
- 101150012394 PHO5 gene Proteins 0.000 description 1
- 241000588912 Pantoea agglomerans Species 0.000 description 1
- 101100382106 Paraclostridium bifermentans cry16Aa gene Proteins 0.000 description 1
- 108010087702 Penicillinase Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010090127 Periplasmic Proteins Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 241000130993 Scarabaeus <genus> Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000613125 Teleogryllus oceanicus Species 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 description 1
- 208000013521 Visual disease Diseases 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- OIRDTQYFTABQOQ-UHFFFAOYSA-N ara-adenosine Natural products Nc1ncnc2n(cnc12)C1OC(CO)C(O)C1O OIRDTQYFTABQOQ-UHFFFAOYSA-N 0.000 description 1
- 101150035354 araA gene Proteins 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000012219 cassette mutagenesis Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000005081 chemiluminescent agent Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- OZRNSSUDZOLUSN-LBPRGKRZSA-N dihydrofolic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-LBPRGKRZSA-N 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 101150045500 galK gene Proteins 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 101150085823 hsdR gene Proteins 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 101150023497 mcrA gene Proteins 0.000 description 1
- 101150079876 mcrB gene Proteins 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229950009506 penicillinase Drugs 0.000 description 1
- 108010021711 pertactin Proteins 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 101150015201 rbsR gene Proteins 0.000 description 1
- 101150090336 regB gene Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 101150098466 rpsL gene Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- the present applicant has now found that three regions of the pADAP plasmid are required for full insecticidal function. Sequence analysis of these three regions has shown that the present applicant has isolated and identified a novel toxin from Serratia species that belongs to a new family of insecticidal toxins. It is broadly to this toxin that the present invention is directed.
- an isolated nucleic acid molecule comprising a nucleotide sequence of SEQ ID NO: 1 which encodes an insecticidal protein complex, or a functional fragment, neutral mutation, or homolog thereof capable of hybridising with said nucleic acid molecule under standard hybridisation conditions.
- the invention also provides an isolated nucleic acid molecule comprising the nucleotide sequence 1995-18937 of SEQ ID NO: 1 which encodes an insecticidal protein complex, or a functional fragment, neutral mutation, or homolog thereof capable of hybridising with said nucleic acid molecule under standard hybridisation conditions.
- the invention also provides an isolated nucleic acid molecule comprising one or more of the nucleotide sequences 2411-9547, 9589-13883 or 14546-17467 of SEQ ID NO: 1 which encode insecticidal proteins, or a functional fragment, neutral mutation, or homolog thereof capable of hybridising with said nucleic acid molecule under standard hybridisation conditions.
- the nucleic acid molecule comprises all of nucleotide sequences 2411-9547, 9598-13884 and 14546-17467 of SEQ ID NO: 1.
- the invention further relates to an isolated nucleic acid molecule comprising a sequence of SEQ ID NO: 1, nucleotides 1955-18937 of SEQ ID NO: 1 or one or more of nucleotides 2411-9547, 9598-13884 or 14546-17467 of SEQ ID NO: 1, operably linked to at least one further nucleotide sequence which encode an insecticidal protein.
- the at least one further nucleotide sequence may be the nucleotide sequence which codes for the Bacillus delta endo toxins, vegatative insecticidal proteins (vips), cholesterol oxidases, Clostridium bifermentens mosquitocidal toxins and or Photorhabadus luminescens toxins and so forth.
- the nucleic acid molecule may comprise DNA, cDNA or RNA.
- said fragment, neutral mutation or homolog thereof is capable of hybridising to said nucleic acid molecule under stringent hybridisation conditions.
- the invention further relates to nucleic acid molecules which hybridise to the nucleotide sequence of SEQ ID NO: 1, or nucleotides 1955-18937, 2411-9547, 9598-13884 or 14546- 17467 of SEQ ID NO: 1 if there is at least 50%, preferably 60%, more preferably 70% and most preferably 90-95% or greater identity between the sequences.
- the nucleic acid molecule may be isolated from Serratia entomophila or Serratia proteamaculans strains.
- Also provided by the present invention are recombinant expression vectors containing the nucleic acid molecule of the invention and hosts transformed with the vector of the invention capable of expressing a polypeptide of the invention.
- the vector may be selected from any suitable natural or artificial plasmid/vector.
- pUC 19 Yamamoto et al. 1995
- pProEX HT Gaithersburg, MD, USA
- pBR322 Bolivar et al. 1977
- pACYC184 Chang et al. 1978
- pLAFR3 Staskowicz et al. 1987
- the invention provides a method of producing a polypeptide of the invention comprising the steps of:
- An additional aspect of the present invention provides a ligand that binds to a polypeptide of the invention.
- the ligand is an antibody or antibody binding fragment.
- Such ligands also form a part of this invention.
- probes and primers comprising a fragment of the nucleic acid molecule of the invention capable of hybridising under stringent conditions to a native insecticidal gene sequence.
- probes and primers are useful, for example, in studying the structure and function of this novel gene and for obtaining homologs of the gene from bacteria other than Serratia sp.
- a polypeptide having insecticidal activity encoded by the nucleic acid molecule of the invention, or a functional fragment, neutral mutation or homolog thereof.
- the polypeptide may comprise the amino acid sequence of SEQ ID NO: 1 or a functional fragment, neutral mutation or homolog thereof.
- the polypeptide may comprise amino acids 32-5118 of SEQ ID NO: 1.
- the polypeptide may comprise at least one amino acid sequence of SEQ ID NO: 2; SEQ ID NO: 3; SEQ ID NO: 4; SEQ ID NO: 5 or SEQ ID NO: 6.
- polypeptide comprises amino acid sequence SEQ ID NO: 4; SEQ ID NO: 5 and SEQ ID NO: 6.
- polypeptide comprises all of SEQ ID NOs: 2-6.
- the polypeptide of the invention is obtained by expression of a DNA sequence coding therefore in a host cell or organism.
- the polypeptide may comprise the amino acid sequence of SEQ ID NO: 1 linked to at least one further amino acid sequence encoding an insecticidal protein.
- the at least one further amino acid sequence may be the amino acid sequence which codes for Bacillus delta endo toxins, vegatative insecticidal proteins (vips), cholesterol oxidases, Clostridium bifermentens mosquitocidal toxins and/or Photorhabadus luminescents toxins etc.
- the invention further relates to polypeptides comprising at least 50%, preferably 60%, more preferably 70% and most preferably 90-95% or greater identity to SEQ ID NO: 1.
- the polypeptide may be produced by expression of a vector comprising the nucleic acid molecule of the invention or a functional fragment, neutral mutation or homolog thereof, in a suitable host cell.
- an insecticidal composition comprising at least the polypeptide of the invention and an agriculturally acceptable carrier such as would be known to a person skilled in the art. More than one polypeptide of the invention can of course, be included in the composition.
- the composition may comprise one or more additional pesticides, for example, compounds known to possess herbicidal, fungicidal, insecticidal or nematicidal activity.
- composition may further comprise other known insecticidally active agents, such as Bacillus delta endo toxins, vegatative insecticidal proteins (vips), cholesterol oxidases, Clostridium bifermentens mosquitocidal toxins and/or Photorhabadus luminescents toxins
- insecticidally active agents such as Bacillus delta endo toxins, vegatative insecticidal proteins (vips), cholesterol oxidases, Clostridium bifermentens mosquitocidal toxins and/or Photorhabadus luminescents toxins
- a method of combating pests especially insects at a locus or host for the pest infested with or liable to be infested therewith, said method comprising applying to a locus, host and/or the pest, an effective amount of the polypeptide of the invention that has functional insecticidal activity against said pest.
- the invention provides a method of inducing amber disease or like condition in insects comprising delivery to an insect an effective amount of the polypeptide of the invention that has functional insecticidal activity against said insect.
- the insect may be selected from the order comprising Coleoptera (such as the black beetle, Heteronychus arator (F.), or the black vine weevil, Otiorhynchus sulcatus (F.)); Dictyoptera ⁇ eg. The German cockroach, Blattella germanica (L.), or the subterranean termite Coptotermes spp,); Diptera (eg. the housefly Musca domestica L. or the blowfly Lucillia cuprina (Wiedermann); Orthoptera (eg. The black field cricket Telleogryllus commodus (Walker) or the migratory locust Locusta migratoria L.); Hymenoptera (eg.
- Coleoptera such as the black beetle, Heteronychus arator (F.), or the black vine weevil, Otiorhynchus sulcatus (F.)
- Dictyoptera ⁇ eg.
- Hemiptera such as the green vegetable bug Nezara viridula (L.) or the green peach aphid Myzus persicae (Sulzer)
- the Lepidoptera eg. the tomato fruitworm, Helicoverpa armigera (Walker), or the codling moth, Laspeyresia pomonella (L.)
- the Lepidoptera eg. the tomato fruitworm, Helicoverpa armigera (Walker), or the codling moth, Laspeyresia pomonella (L.)
- the insecticidal polypeptide may be delivered to the insect orally either as a solid bait matrix, as a sprayable insecticide sprayed onto a substrate upon which the insect feeds, applied directly to the soil subsurface or as a drench or is expressed in an transgenic plant, bacterium, virus or fungus upon which the insect feeds, or by any other suitable method which would be obvious to a person skilled in the art.
- the invention provides a transgenic plant, bacterium virus or fungus, incorporating in its genome, a nucleic acid molecule of the invention providing the plant, bacterium virus or fungus with an ability to express an effective amount of an insecticidal polypeptide.
- nucleic acid or polypeptide refers to a naturally-occurring nucleic acid or polypeptide, including, wild-type sequence and alleles thereof.
- a “homolog” has at least one of the biological activities of the nucleic acid or polypeptide of the invention and comprises at least 50-70% identical amino acid or nucleic acid sequence thereto, preferably 75-85% and most preferably 90-95% identical amino acid or nucleic acid sequence thereto.
- neutral mutation means a mutation, (that is - a change in the nucleotide or polypeptide sequence such as by deletion, substitution, inversion or insertion, any of which have no effect on the function of the encoded protein).
- variants of the polypeptide or peptide that differ from the native amino acid sequence by insertion, substitution or deletion of one or more amino acids.
- the nucleotide sequence of the native DNA is altered appropriately. This alteration can be made through elective synthesis of the DNA, or by modification of the native DNA by, for example, site specific or cassette mutagenesis.
- site-directed synthesis of the DNA or by modification of the native DNA by, for example, site specific or cassette mutagenesis.
- portions of cDNA or genomic DNA require sequence modifications, site-
- the present invention consists in replicable transfer vector suitable for use in preparing a polypeptide of the invention.
- replicable transfer vectors suitable for use in preparing a polypeptide of the invention.
- These vectors may be constructed according to techniques well known in the art, or may be selected from cloning vecotrs available in the art.
- the cloning vector may be selected according to the host or host cell to be used.
- Useful vectors will generally have the following characteristics:
- (c) desirably, carry genes for a readily selectable marker such as antibiotic resistance.
- vectors Two major types of vector possessing these characteristics are plasmids and bacterial viruses (bacteriophages or phages).
- plasmids include plasmids pMOS- Blue, pGem-T and pUC8.
- nucleic acids of the present invention can be free in solution, or attached by conventional means to a solid support, or present in an expression vector or any other type of plasmid.
- isolated means substantially separated or purified away from contaminating sequences in the cell or organism in which the nucleic acid naturally occurs and includes nucleic acids purified by standard purification techniques as well as nucleic acids prepared by recombinant technology and those chemically synthesised.
- DNA construct means a construct incorporating the nucleic acid molecule of the present invention, or a fractional fragment, neutral mutation or homolog thereof in a position whereby the protein coding sequence is under the control of an operably linked promoter capable of expression in a plant cell.
- promoters are well known in the art.
- a fragment of a nucleic acid molecule according to the present invention is a portion of the nucleic acid that is less than full length and comprises at least a minimum length capable of hybridising specifically with a nucleic acid molecule according to the present invention (or a sequence complementary thereto) under stringent conditions as defined below.
- a fragment according to the present invention has at least one of the biological activities of the nucleic acid or polypeptide of the present invention.
- Nucleic acid probes and primers can be prepared based on nucleic acids according to the present invention (for example, the sequence of SEQ ID NO: 1).
- a "probe” comprises an isolated nucleic acid attached to a detectable label or reporter molecule well known in the art. Typical labels include radioactive isotopes, ligands, chemiluminescent agents, and enzymes.
- Primer pairs are short nucleic acids, preferably DNA oligonucleotides 15 nucleotides or more in length, which are annealed to a complementary target DNA strand by nucleic acid hybridisation to form a hybrid between the primer and the target DNA strand, then extended along the target DNA strand by a polymerase, preferably a DNA polymerase. Primer pairs can be used for amplification of a nucleic acid sequence, (for example, by the polymerase chain reaction (PCR) or other nucleic acid amplification methods well known in the art).
- PCR polymerase chain reaction
- PCT-primer pairs can be derived from the sequence of a nucleic acid according to the present invention, (for example, by using computer programs intended for that purpose such as Primer (Version 0.5 ⁇ 1991 , Whitehead Institute for Biomedical Research, Cambridge, MA)).
- Probes or primers can be free in solution or covalently or noncovalently attached to a solid support by standard means.
- operably linked means a first nucleic acid sequence linked to a second nucleic acid sequence when the first nucleic acid sequence is placed in a functional relationship with the second nucleic acid sequence.
- a promoter is operably linked to a coding sequence if the promoter affects the transcription or expression of the coding sequence.
- operably linked DNA sequences are contiguous and, where necessary to join two protein coding regions, in reading frame.
- the DNA molecules of the invention may be expressed by placing them in operable linkage with suitable control sequences in a replicable expression vector.
- Control sequences may include origins of replication, a promoter, enhancer and transcriptional terminator sequences, amongst others.
- the selection of the control sequence to be included in the expression vector is dependent on the type of host or host cell intended to be used for expressing the DNA.
- a "recombinant" nucleic acid is one that has a sequence that is not naturally occurring or has a sequence that is made by an artificial combination of two otherwise separated segments of sequence. This artificial combination is often accomplished by chemical synthesis or, more commonly, by the artificial manipulation of isolated segments of nucleic acids (for example, by genetic engineering techniques).
- nucleic acid according to the present invention can be produced by recombinant means well known in the art or by chemical synthesis.
- Natural or synthetic nucleic acids according to the present invention can be incorporated into recombinant nucleic acid constructs, typically DNA constructs, capable of introduction into and replication in a host cell.
- DNA constructs will be suitable for replication in a unicellular host, such as E. coli or other commonly used bacteria, but can also be introduced into yeast, mammalian, plant or other eukaryotic cells.
- such a nucleic acid construct is a vector comprising a replication system recognised by the host.
- a vector comprising a replication system recognised by the host.
- well known compositions and techniques for preparing and using vectors, host cells, introduction of vectors into host cells and so forth., are employed, as discussed, inter alia, in Sambrook et al (1989).
- a cell, tissue, organ, or organism into which has been introduced a foreign nucleic acid, such as a recombinant vector, is considered “transformed” or "transgenic".
- the DNA construct comprising a DNA sequence according to the present invention that is present in a transgenic host cell, particularly a transgenic plant, is referred to as a "transgene”.
- transgenic or “transformed” when referring to a cell or organism, also includes;
- procaryotic, yeast, insect, or mammalian cells are useful hosts.
- plasmid vectors include E. coli, Bacillus species and various species of Pseudomonas.
- Commonly used promoters such as ⁇ -lactamase (penicillinase) and lactose (lac) promoter systems are all well known in the art. Any available promoter system compatible with the host of choice can be used.
- Vectors used in yeast are also available and well known. A suitable example is the 2 micron origin
- vectors for use in mammalian cells are also well known.
- Such vectors include well known derivatives of SV-40, adenovirus, retrovirus-derived DNA sequences, Herpes simplex virus, and vectors derived from a combination of plasmid and phage DNA.
- the expression vectors useful in the present invention contain at least one expression control sequence that is operatively linked to the DNA sequence or fragment to be expressed.
- the control sequence is inserted in the vector in order to control and to regulate the expression of the cloned DNA sequence.
- useful expression control sequences are the lac system, the trp_ system, the tac system, the trc system, major operator and promoter regions of phage lambda, the glycolytic promoters of yeast acid phosphatase, (for example, Pho5), the promoters of the yeast alpha-mating factors, and promoters derived fron polyoma, adenovirus, retrovirus, and simian virus (for example, the early and late promoters of SV-40), and other sequences known to control the expression of genes of prokaryotic and eucaryotic cells and their viruses or combinations thereof.
- Reporter systems useful in such assays include reported genes, and other detectable labels which produce measurable colour changes, antibiotic resistance and the like.
- the ⁇ -galactosidase reporter gene is used, which gene is detectable by clones exhibiting a blue phenotype on X-gal plates. This facilitates selection.
- the ⁇ -galactosidase gene may be replaced by a polyhedrin-encoding gene; which gene is detectable by clones exhibiting a white phenotype when stained with X-gal.
- This blue-white colour selection can serve as a useful marker for detecting recombinant vectors.
- the vectors may be isolated from the culture using routine procedures such as freeze-thaw extraction followed by purification.
- vectors containing the DNA of the invention to be expressed and control signals are inserted or transformed into a host or host cell.
- Some useful expression host cells include well-known prokaryotic and eucaryotic cells.
- Some suitable prokaryotic hosts include, for example, E. coli, such as E. coli, S G-936, E. coli HB 101, E. coli W3110, E. coli XI 776, E. coli, X2282, E. coli DHT and E. coli MR01, Pseudomonas, Bacillus ⁇ such as Bacillus subtilis and Streptomyces.
- Suitable eucaryotic cells include yeast and other fungi, insect, animal cells, such as COS cells and CHO cells, human cells and plant cells in tissue culture.
- transformation is performed according to standard techniques appropriate to such cells.
- the calcium treatment process (Cohen, S N Proceedings, National Academy of Science, USA 69 21 10 (1972)) may be employed.
- the calcium phosphate precipitation method of Graeme and Van Der ⁇ b, Virology 52:546 (1978) is preferred. Transformations into plants may be carried out using Agrobacterium tumefaciens (Shaw et al., Gene 23:315 (1983)) or into yeast according to the method of Van
- polypeptide, or peptide encoded can be produced, often in the form of fusion protein, by culturing the host cells.
- the polypeptide, or peptide, of the invention may be detected by rapid assays as indicated above.
- the polypeptide, or peptide is then recovered and purified as necessary. Recovery and purification can be achieved using any of those procedures known in the art, for example by absorption onto the elution from an anion exchange resin. This method of producing a polypeptide, or peptide, of the invention constitutes a further aspect of the present invention.
- Host cells transformed with the vectors of the invention also form a further aspect of the present invention.
- nucleic acids Methods for chemical synthesis of nucleic acids are well known and can be performed, for example, on commercial automated oligonucleotide synthesisers.
- stringent conditions is functionally defined with regard to the hybridisation of a nucleic acid probe to a target nucleic acid (for example, to a particular nucleic acid sequence of interest) by the hybridisation procedure discussed in Sambrook et al. (1989) at 9.52-9.55 and 9.56-9.58.
- stringent conditions are conditions that permit the primer pair to hybridise only to the target nucleic acid sequence to which a primer having the corresponding wild type sequence (or its complement) would bind.
- Nucleic acid hybridisation is affected by such conditions as salt concentration, temperature, or organic solvents, in addition to the base composition, length of the complementary
- the term "specific for (a target sequence)" indicates that the probe or primer hybridises under stringent conditions only to the target sequence in a given sample comprising the target sequence.
- protein refers to a protein encoded by the nucleic acid molecule of the invention including fragments, mutations and homologs having the same biological activity (for example, insecticidal activity).
- the polypeptide of the invention can be isolated from a natural source, produced by the expression of a recombinant nucleic acid molecule or be chemically synthesised.
- substantially sequence identity means that two peptide sequences, when optimally aligned, such as by the programs GAP or BESTFIT using default gap weights, share at least 80% sequence identity, preferably at least 90% sequence identity, more preferably at least 95% sequence identity or more.
- residue positions that are not identical differ by conservative amino acid substitutions. For example, the substitution of amino acids having similar chemical properties such as charge or polarity are not likely to effect the properties of a protein. Examples include glutamine for asparagine, or glutamic acid for aspartic acid.
- Figure 1 shows restriction maps of clones used to isolate the pathogenic region and maps of the two pathogenic variants pMH32 and pMH41, in accordance
- Figure 2 shows deletion derivatives used in the study, restriction maps of the mutated constructs and recombinants, the phenotype of each mutation, the schematic diagram of the sequenced region, and a nucleotide sequence in accordance v with a preferred embodiment of the present invention
- Figure 3 shows hydrophobicity plots of SepC and its closest homologue TccC, in accordance with a preferred embodiment of the present invention.
- Figure 4 shows the comparison of protein sequences of the SepA and P. luminescens toxins, TcdA, TcaB and TccB Putative RGD motif is boxed, plus the site of proteolytic cleavage is illustrated, in accordance with a preferred embodiment of the present invention.
- Figure 5 shows the comparison of protein sequences of the SepC and P. luminescens toxin TccC, in accordance with a preferred embodiment of the present v invention.
- Figure 6 shows the plasmid pADAP, in accordance with a preferred embodiment of the present invention.
- Figure 1 shows restriction maps of clones used to isolate the pathogenic region and maps of the two pathogenic variants pMH32 and pMH41, where:
- Map of pBG35 showing relative position of pGLA-20-35 mutation and the location of the 2.2kb EcoRi used as a probe to screen the pADAP BamHI library;
- Restriction enzymes are abbreviated as follows: B, BamHI, Bg, BglR; E, Ec ⁇ RI: H, HindiS; and X, Xbal.
- Restriction enzymes are abbreviated as follows: B, BamHI, Bg, BglR; E, EcoRI; H, HindSl; and X, Xbal.
- BI Denotes sequenced region.
- (E) Is a nucleotide sequence of the 5 times 12bp repeat and the palindrome.
- Restriction enzymes are abbreviated as follows: B, ⁇ HI, Bg, BglR; E, EcoRI; H, HindSl; and X, Xbal.
- Figure 4 shows the comparison of protein sequences of the SepA and P. luminescens toxins, TcdA, TcaB and TccB. Putative RGD motif is boxed. The site of proteolytic cleavage is reported by Bowen et al. (1998) (Residue 1933 of TcdA) is indicated by an arrow.
- Figure 5 shows the comparison of protein sequences of the SepC and P. luminescens toxin TccC; and Figure 6 shows the plasmid pADAP.
- Table 1 lists bacterial isolates and plasmids used in the present invention. Bacteria were grown in LB broth or on LB agar (Sambrook et al. 1989), at 37° for Escherichia coli and 30°C for S. entomophila. Antibiotic concentrations used ( ⁇ g/ml) for Serratia were kanamycin 100, chloramphenicol 90, tetracycline 30 and for E. coli strains were kanamycin 50, chloramphenicol 30, tetracycline 15, and ampicillin 100.
- pADAP DNA was isolated from a 50ml overnight culture of bacteria using QIAGEN ® plasmid maxi kit (Qiagen, Hilden, Germany), as per the manufacturer's instructions. Standard DNA techniques were carried out as described by Sambrook et al. (1989). Radioactive probes were made using the Amersham Megaprime DNA labeling system (Amersham, ⁇ Buckinghamshire, UK). Southern and colony hybridisations were performed as outlined in Sambrook et al. (1989). The plasmid pADAP is shown in Figure 6.
- pADAP BamHI library was constructed using a Sigma 'Gigapack ® ⁇ LXL packaging extract, as specified by the manufacturer (Stratagene, California, USA).
- pLAFR3 based derivatives were introduced into S. entomophilia by tripartite matings on solid media as described previously (Finnegan & Sheratt, 1982) using the pRK2013 helper plasmid (Figorski & Helanski, 1979).
- pACYC184 and ⁇ BR322 based plasmids were electroporated into E. coli and S. entomophilia strains, using a Biorad Gene Pulser (2 ⁇ F, 2.5KV, and 200 abns) (Dower et al. 1988).
- Transposon insertions were generated in recombinant plasmids using the mmi-TnlO derivative 103 (kanamycin resistant) as described by Kleckner et al. (1991). Insertions were recombined into pADAP by transforming A1MO2 (refer to Table 1) with the described construct. After growth in non-selective media, bacteria were screened for resistance to kanamycin and loss of the pLAFR3 tetracycline resistance marker.
- Infection of C. zealandica larvae was determined by a standard bioassay where the healthy larvae, collected from the field, were individually fed squares of carrot which had been rolled in colonies of bacteria grown overnight on solid media (resulting in approximately 10 5 cells/carrot square). Twelve, second or third instar larvae were used for each treatment. Inoculated larvae were maintained at 15°C, in ice-cube trays. Larvae were left feeding on treated carrot for 3-4 days, then transferred to fresh trays and provided with untreated carrot for 10-14 days. The occurrence of gut clearance and loss of feeding was recorded every 3-4 days. Strains were considered disease-causing if greater than 70% of larvae showed disease symptoms by day 14. Known pathogenic and non pathogenic controls were included in all bioassays. Typically cessation of feeding occurs within 2-3 days while clearance of the larvae gut may take 4-6 days.
- a 9-kb BamHI -EcoRl fragment derived from the pBM32-8 mutation (Fig 2b) and the 8kb HindRl fragment of pBM32 were separately cloned into the appropriate site of the deletion factory plasmid pDELTAl. Deletions were generated using the Delection factoryTM system (GIBCO BRL, MD, USA), as outlined in the manufacturers instructions. To identify the precise location of mini-7hi0 mutations, the peripheral -TnlO BamHI sites were used in conjunction with the BamHI sites of the pathogenic region to subclone the mini-7ni0 flanking regions into either pACYC184 or pUC19. Sequences were generated using the mini-TnlO specific primer 5 ⁇ TGACAAGATGTGTATCCACC3' (Kleckner et al. 1991).
- Plasmids for sequencing were prepared by Wizard ® (Promega, Madison, USA) or Quantum Prep ® (Bio-Rad, California, USA) miniprep kits. Sequences were determined on both strands, by using combinations of subcloned fragments, custom primers and deletion products derived from the deletion factory system (Gibco BRL, Madison, USA). The DNA was sequenced using either 3 P dCTP and the Thermosequenase cycle sequencing kit (Amersham, Buckinghamshire, UK), or by automated sequencing using an Applied Biosystem 373A or 377 autosequencer. Sequence data were assembled using SEQMAN (DNASTAR Inc., Madison, USA). ORF's were analysed by Gene Jockey.
- the resultant digest was ligated into the BamHI site of bBR322 to form the construct pBG35 (containing 12.8kb BglR - mm ' i-TnlO fragment).
- pBG35 was placed separately in trans with pADK-10 and pGLA-20, and the resultant strains bioassayed against grass grub larvae. Results showed that pBG35 was able to complement the pADK-10 mutant, but was unable to induce any symptoms of amber disease when placed in trans with pGLA-20, indicating that there must be another region on pADAP needed to induce amber disease.
- the plasmids pMH32 and pMH41 were subsequently introduced into a S. entomophilia strain cured of pADAP (5.6RC) and the strains bioassayed against grass grub larvae. The strains gave the same disease progression as wild type and no larvae recovered, suggesting that the region cloned in pMH32 contained all the pathogenic determinants of pADAP.
- the 23kb BamHI fragment from pMH32 was cloned into the medium copy plasmid pBR322 to give pBM32.
- a bioassay comparing the ability of pMH32 and pBM32 to induce amber disease against grass grub was undertaken. Results showed that there were no visual differences in the progression of amber disease between pBM32 and pMH32.
- the construct pBM32 was mutated with the mini-7n70 transposon derivative 103, and insertions mapped (Fig 2b). Bioassays of E. coli strains containing plasmids of the resultant mutants, showed that the disease determinants were confined within a central 16.9kb region (nucleotides 1955-18937 of SEQ ID NO: 1).
- pBM32 based insertions were transferred into pADAP.
- DNA fragments containing the inserted transposon and flanking DNA were cloned as independent fragments into pLAFR3 and the inserts recombined back into pADAP by marker exchange (Fig 2c). The resultant recombinant S.
- the large BamHI fragment (18937 bp) derived from the pBM32-8 was sequenced on both strands using a combination of constructed detections, plasmid subclones and custom made primers.
- a total continuous sequence of 18937 bp has been deposited in Gene Bank (Accession Number AF 135182).
- Structural analysis of the DNA sequence using DNAMAN showed that there was a 12-bp sequence repealed five times between positions 683 and 743. The repeat is flanked by an upstream 13 base pair palindrome (669-682-bp), and a degenerate 34-bp downstream palindrome (765-799-bp)(Fig 2d,e).
- ORF's open reading frames
- the protein product of sepA had high similarity to the P. luminescents insecticidal toxin complex protein TcbA, TcdA, TcaB and TccB. These proteins shared three significant tasks
- SepB and the P. luminescens insecticidal toxin complex protein TcaC shared similarity throughout their length, and both SepA and TcaC showed high amino-terminal similarity to the Salmonella virulence protein spvB (Gullig et al. 1992) (Fig. 5).
- the similarity of SepB and TcaC to SprB diminishes after SpvB amino acid residue 356.
- SepC showed strong similarity to the amino-terminal of the insecticidal toxin complex protein TccC, up to amino-acid residue 663 of SepC.
- a number of putative bacterial cell wall proteins also have high similarity to SepC, including the wall associated protein precursor B. subtilis (WAP A) and members of the E. coli Rhs (recombinant hot spot) elements. Strong similarity of SepC was also observed with hypothetical wall-associated proteins from Coxiella burnetti and Bacillus subtilis (Table 4).
- ORF1 and ORF2 showed no similarity to sequences in the current databases.
- ORF3 shared significant similarity to the morphogenesis protein of the Bacillus subtilis bacteriophage B103, a member of bacteriophage muramidase-type lysis proteins (Pecenkova et al. 1996). However, relative to size, the gpl9 protein of S. typhimurium phage ⁇ S18 (146 amino-acid residues) or the nucD/regB phage lysozymes of S. marcescens (179 amino-acid residues) are more similar.
- ORF4 showed similarity to E. coli bacteriophage N15gp 55 protein, a protein of unknown function (Zimmer et al. 1998).
- 27 termination codon is a 204 base pair region assigned ORF5, which has high similarity to a S. typhimurium revol vase/in vertase protein.
- ORF5 is disrupted by two stop codons at amino-acid residues 19 and 64, making it unlikely that an active resolvase/invertase protein, is encoded by this region.
- a 256-bp region of encompassed by ORF5 (17498-17754) showed high similarity (77% identity) to the region (AF020806; 1629-1885 bp) encoding S. typhimurium DNA invertase gene (Valdivia et al. 1997) suggesting a similar ancestral origin. ⁇
- ORF6 Downstream of ORF5 and oriented in the opposite direction from 18935-18163 was a 870 base pair region of DNA designated ORF6 whose product showed high amino-acid similarity over two different reading frames to the insertion element IS9 ⁇ of E. coli (Mendiola et al. 1992). The translated sequence is interrupted at amino-acid residue 149 of the IS9 ⁇ element and later resumed on a second reading frame, before its similarity switched back to the original reading frame. Swtiching of ORF's is a common feature of members of the IS3 family where the transposase is encoded by this overlapping ORF's (Prere et al. 1990). However, the switch back to the initial strand is atypical. ORF6 may therefore be a dysfunctional relic of an ancestral IS element. It is unknown whether ORF6 contains a ribosomal binding site as its predicted location would lie outside the sequenced region. There was no DNA similarity to the 7591 element.
- RGD tripeptide cell-binding motif Asp-Gly-Arg
- the RGD motif is present in cell surface adhesions produced by the human pathogen Bordetella pertussis, namely the filamentous heamagglutinin (220 kDa) (Relman et al. 1989), and the outer membrane protein pertactin (69 kDa) (Leininger et al. 1991).
- Bordetella pertussis namely the filamentous heamagglutinin (220 kDa) (Relman et al. 1989), and the outer membrane protein pertactin (69 kDa) (Leininger et al. 1991).
- These motifs have been implicated in enhancing the binding of B. pertussis to eukaryotic cells. Because the RGD motif found in SepA falls in a
- SepB and TcaC shared similarity to the Salmonella virulence protein SpvB, the amino-terminil of SepB and TcaC were hydrophilic as opposed to the hydrophobic nature of SpvB.
- the profile of SepC and its Photorhabadus counterpart TccC differed in that SepC had a slightly hydrophilic amino- terminus, whereas TccC lacked a hydrophilic amino-terminus and had a significantly hydrophobic carboxyl terminus from amino-acid residue 717 onwards (Fig. 3).
- the large conjugative plasmid, pADAP, of S. entomophilia encodes the genes responsible for cessation of feeding and gut clearance, characteristics of amber disease in the New Zealand grass grub C. zealandica.
- This plasmid is present in all S. entomophilia and S. proteamaculans strains capable of causing amber disease (Glare et al. 1993) and had been implicated in disease processes (Grkovic et al. 1995).
- the applicant has defined a 16.9 kb region of kADAP that is sufficient to confer pathogenicity towards C. zealandica on pADAP-cured strains of S. entomophilia and on strains of E. coli.
- the region confers all the essential pathogenicity genes of S. entomophilia responsible for amber disease.
- Nucleotide sequence and mutagenesis analysis of the region revealed three genes, SepA, SepB and SepC, that together are sufficient for pathogenicity. Mutations in any of the three genes completely abolished the disease process and partial disease states were not detected, suggesting that the three genes may interact to exert an effect.
- ambl A putative anti-feeding gene, ambl, has already been isolated from the genomic DNA of S. entomophilia (Nunez- Valdez and Mahanty, 1996). Recent data indicate that the ambl locus resides at an as yet to be identified location on pADAP that is remote from the region identified herein (Hurst, unpublished data).
- the similarity shared between the sep and tc gene products suggests that they are members of a new family of insecticidal toxins.
- the Photorhabadus toxins were isolated as a composite of proteins which are hypothesised to interact synergistically to form a toxin complex.
- the toxins are also able to exert an anti-feeding effect (Bowen et al. 1998; Bowen and Ensign, 1998). This is consistent with the results we obtained with the sep mutants.
- pADAP-cured S. entomophilia strains containing the pathogenicity clone pBM32 exert an anti-feeding effect on the grass grub and individual mutations within any of the sep genes have an identical phenotype, completely abolishing pathogenicity.
- the Photorhabadus toxins have a wide host range, affecting Lepidoptera, Coleoptera and Dictyoptera and undergo post translational
- the Photorhabdus toxin TcbA shares weak similarity to the Clostridium difficile A and B toxins (Bowen, 1998), but no such similarities were found to SepA.
- C. difficile A and B toxins belong to the RTX (repeats in toxin) family of toxins which are noted for the presence of several carboxyl terminal repeats (von Eichel-Streiber et al. 1992).
- a search of the sep proteins and their P. luminescens homologues for protein repeats showed that only the P. luminescens TcaC protein contained a repeat-type signature.
- the TcaC carboxy- terminal repeat bears little resemblance in size or number of repeats found in RTX toxins (von Eichel-Streiber et al. 1992). SepA does not show weak similarity to the mosquitocidal toxin Cbm71 of C. bifermentans (Barloy et al. 1996). However when this region is compared with the relevant Photorhabdus homologues, it is a region with little similarity.
- SepB has strong similarities to both P. luminescens TccC and the Salmonella virulence gene product SpvB (Gulig et al. 1992). SpvB is believed to enhance the survival of virulent Salmonella in macrophages (Libby et al. 1997). It has been suggested that TcaC may act by attacking insect haemocytes (Bowen et al. 1998). However, haemocytes reside within the insect haemocoel and S. entomophilia does not invade the haemocoel until late in the infection process (Jackson et al. 1993), suggesting that SepB may act in some other way.
- the SepC protein shows high similarity to a family of cell wall-associated bacterial proteins such as the B. subtilis wall-associated protein (WAP A) and members of the E. coli rhs element family.
- WAP A B. subtilis wall-associated protein
- the function of the Rhs proteins has yet to be established, but they are believed to be cell surface ligand-binding proteins (Hill et al. 1994).
- the Rhs proteins and the B. subtilis was-associated protein contain a characteristic repetitive peptide motif, but no such motif was observed in SepC.
- a feature of rhs elements is the presence of a downstream IS element (Wang et al. 1998).
- a degenerate IS91-type transposase element (ORF6) is present downstream of SepC.
- the IS91 element has been found associated with plasmids or chromosomal genes involved in ⁇ -haemolysin synthesis, and has been postulated to play a pivotal role in the spread of the ⁇ -haemolysin genes by means of the IS91 -mediated recombinational activity (Zabala et al. 1984). It seems possible an IS element adjacent to SepC may have been involved in the acquisition of the sep genes by S. entomophilia.
- the S. entomophilia pathogenicity region endows pathogenicity on members of the Enterobacteraceae such as Klebsiella spp., Enterobacter agglomerans, E. coli, and Serratia
- the Sep proteins are the major virulence determinants, that the promoters of the sep genes are expressed constitutively or under the control of conserved regulatory genes, or a negative regulatory gene present in the pathogenicity region, and that export of the toxin proteins is carried out by a conserved chromosomally encoded system, or is an intrinsic property of the sep proteins.
- the Sep proteins have no obvious amino terminal signal sequences, a facet shared with E-Group colicins.
- the release of cloacin DF13 is mediated through a small lipoprotein designated BRP, for bacteriocin-release protein.
- ORF3 may have an as yet to be determined important functional role. Protein similarity searches show that it has high similarity to the bacteriophage lysozyme family. In relation to amino-acid size, ORF3 closely resembles the LZBP22 lysozyme of the Salmonella P2 bacteriophage, a protein essential for the lysis of the bacterial cell wall (Rennell and Poteete, 1985).
- ORF3 may facilitate the release of the sep proteins by lysing the bacterial cell wall.
- a low level expression of ORF3 might, as in the case of BRP, allow the passage of the sep proteins across the cell wall without causing cell death.
- the reason that the pBM32-9 and -24 mutations were unable to abolish the disease process could be due to a masking of ORF3 function by natural cell lysis of the bacteria.
- a region of repetitive DNA was identified between nucleotides 683 to 743, centered within a 1.2-kb AT rich stretch of DNA that contains no potential ORF's.
- the repeat motif is flanked by an upstream 13-bp palindrome and a degenerate downstream 33-bp palindrome. Repeats have been found to be common sites for recombination (Allgood et al. 1988), or to facilitate the binding of proteins.
- a 66-bp DNA sequence termed the rsk element for reduced serum killing, of the S. typhimurium 95-kb virulence plasmid, comprises of a series
- the initiation codon ATG of the three sep genes (sepA, sepB and sepC) were individually placed into the unique Ndel site (restriction enzyme site CATGG) of the HIS-tag arabinose expression vector pAV2-10 (obtained from Chuck Shoemaker -AgResearch). Because large proteins i.e. greater than 50 kda are limited in their ability to bind to HIS tag affinity columns the carboxyl terminus of each of the Sep proteins did not need to be in frame with the HIS-tag site.
- the use of the chloramphenicol resistant marker provided by the vector pACYC184 enhances the stability to each of the expression constructs i.e. -the antibiotic ampicilin to which the pAV2-10 is resistant too is cleaved in the media to an inactive form leading to possible plasmid free segregants arising. Conversely the antibiotic chloramphenicol is not cleaved heightening the level of plasmid stability under conditions of arabinose induction.
- sepB and sepC genes were placed as derived from pADAP downstream of sepA. Also sepA, sepB and sepC were placed as in pADAP downstream of orf3. This simulated wildtype conditions (i.e. the arrangement of the sep genes on pADAP) and hopefully get the production of the sep genes and the complex driven off the one upstream promoter. A method which Western analysis has shown to be successful -with moderate levels of sepA, sepB and sepC being detected.
- the arabinose expression system is one of the tightest systems known with almost complete abolition of gene product under arabiniose free conditions Guzman et al. (1995), this abolition can be enhanced by providing glucose to the medium. In contrast providing arabinose at the concentration of 0.2% will switch the arabinose promoter on express any genes under its control e.g. sepA etc.
- an overnight culture of the E. coli strain was set up the next day an 100 ⁇ l of the culture was suspended in fresh media supplemented with chloramphenicol (30 ⁇ g/ml) the culture was grown until an OD of 400 at which time arabinose was added to the culture to a final concentration of 0.2% and the culture left shaking at 30 °C for 18 hours.
- Each of the following Coleopteran species were mouth injected with 3-5 ⁇ l of an overnight suspension of induced bacteria (E. coli strain DHB101) containing either SepA, SepB and SepC or orf3, SepA, SepB and SepC.
- E. coli strain DHB101 induced bacteria
- the region containing pathogenic determinants of the disease has been cloned, and further defined by mutagenesis and deletion analysis to a 16.9 kb region. Sequence analysis of the minimal pathogenic encoding region showed significant protein homology, but little sequence homology to a group of newly described toxins from a member of the Enterobacteriaceae, Photorhabadus luminescens.
- This pathogenicity-encoding region from S. entomophilia plasmid pADAP is the subject of the invention.
- the proteins encoded by the genes (sepA, sepB, sepC) within the 16.9 kb region can be used for insect control whether as an inundative pesticide, within baits or expressed in other organisms such as plants or microbes.
- Salmonella typhimurium virulence plasmid Salmonella typhimurium virulence plasmid. Mol. Microbiol. 6 : 1395-1411.
- Max efficiency DH10BTM A host for cloning methylated DNA.
- amb2 locus from Serratia entomophila confers anti-feeding effect on larvae of
- Bacteriophage B103 complete DNA sequence of its genome and relationship to other
- Rhs elements comprise three subfamilies which diverged prior to acquisition by
- M13 phage cloning vectors and host strains nucleotide sequence of M13mpl8 and pUC 19 vectors. Gene 33, 103-119.
- Lysis gene modules in the phage P22 gene pool Zimmer A Institute for Genetics and Microbiology, University of Kunststoff, Maria-Ward-Str. la, Muenchen D-80638, Germany XI 67137. Accession number (AF064539).
- Percent identities and similarities were calculated in relation to the deduced gene products of the sequenced ORF. 'indicates position of amino-acid similarity in relation to sequence generated in this study. ⁇ indicates position of amino-acid similarity in relation to data base protein sequence. * reading frame. ⁇ similarities were considered potentially significant if the BlastP score exceeded e' 5 . 48
- a purified and isolated nucleic acid molecule comprising a nucleotide sequence of SEQ ED NO: 1 that encodes at least one of:
- a purified and isolated nucleic acid molecule as claimed in Claim 1 comprising the nucleotide sequence 1995-18937 of SEQ ID NO: 1.
- a purified and isolated nucleic acid molecule as claimed in Claim 1 comprising one or more of the nucleotide sequences 2411-9547, 9589-13883 or 14546-17467 of SEQ ID NO: 1.
- a purified and isolated nucleic acid molecule as claimed in Claim 3 comprising all of nucleotide sequences 241 1-9547, 9598-13884 and 14546-17467 of SEQ ID NO: 1.
- a purified and isolated nucleic acid molecule as claimed in Claim 1 comprising a sequence of SEQ ID NO: 1, operably linked to at least one further nucleotide sequence which encode an insecticidal protein.
- a purified and isolated nucleic acid molecule as claimed in Claim 2 comprising nucleotides 1955-18937 of SEQ ID NO: 1 , operably linked to at least one further nucleotide sequence which encode an insecticidal protein.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Pest Control & Pesticides (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Agronomy & Crop Science (AREA)
- Cell Biology (AREA)
- Insects & Arthropods (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU74619/00A AU7461900A (en) | 1999-09-02 | 2000-09-04 | Nucleotide sequences |
NZ517478A NZ517478A (en) | 1999-09-02 | 2000-09-04 | Nucleotide sequences encoding an insecticidal protein complex from serratia |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ337610 | 1999-09-02 | ||
NZ33761099 | 1999-09-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001016305A2 true WO2001016305A2 (en) | 2001-03-08 |
WO2001016305A3 WO2001016305A3 (en) | 2002-01-10 |
Family
ID=19927486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NZ2000/000174 WO2001016305A2 (en) | 1999-09-02 | 2000-09-04 | Nucleotide sequences encoding an insectidal protein complex from serratia |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7461900A (en) |
WO (1) | WO2001016305A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011002992A1 (en) * | 2009-07-02 | 2011-01-06 | Athenix Corp. | Axmi-205 pesticidal gene and methods for its use |
CN102899304A (en) * | 2011-07-26 | 2013-01-30 | 中国科学院上海生命科学研究院 | Protein having phytopathogen killing activity, and coding gene and application thereof |
US9394345B2 (en) | 2013-03-15 | 2016-07-19 | Pioneer Hi-Bred International, Inc. | PHI-4 polypeptides and methods for their use |
US9862965B2 (en) | 2011-07-28 | 2018-01-09 | Athenix Corp. | AXMI205 variant proteins and methods of use |
US10023877B2 (en) | 2013-03-15 | 2018-07-17 | Pioneer Hi-Bred International, Inc. | PHI-4 polypeptides and methods for their use |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997017432A1 (en) * | 1995-11-06 | 1997-05-15 | Wisconsin Alumni Research Foundation | Insecticidal protein toxins from photorhabdus |
WO1998008388A1 (en) * | 1996-08-29 | 1998-03-05 | The Minister Of Agriculture Fisheries & Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain & Northern Ireland | Pesticidal agents |
WO1998008932A1 (en) * | 1996-08-29 | 1998-03-05 | Dow Agrosciences Llc | Insecticidal protein toxins from $i(photorhabdus) |
WO1999042589A2 (en) * | 1998-02-20 | 1999-08-26 | Novartis Pharma Ag. | Insecticidal toxins from photorhabdus |
-
2000
- 2000-09-04 WO PCT/NZ2000/000174 patent/WO2001016305A2/en active IP Right Grant
- 2000-09-04 AU AU74619/00A patent/AU7461900A/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997017432A1 (en) * | 1995-11-06 | 1997-05-15 | Wisconsin Alumni Research Foundation | Insecticidal protein toxins from photorhabdus |
WO1998008388A1 (en) * | 1996-08-29 | 1998-03-05 | The Minister Of Agriculture Fisheries & Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain & Northern Ireland | Pesticidal agents |
WO1998008932A1 (en) * | 1996-08-29 | 1998-03-05 | Dow Agrosciences Llc | Insecticidal protein toxins from $i(photorhabdus) |
WO1999042589A2 (en) * | 1998-02-20 | 1999-08-26 | Novartis Pharma Ag. | Insecticidal toxins from photorhabdus |
Non-Patent Citations (6)
Title |
---|
BOWEN D ET AL: "INSECTICIDAL TOXINS FROM THE BACTERIUM Photorhabdus liminescens" SCIENCE,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,,US, vol. 280, 26 June 1998 (1998-06-26), pages 2129-2132, XP002115650 ISSN: 0036-8075 cited in the application * |
GLARE TRAVIS R ET AL: "Plasmid transfer among several members of the family Enterobacteriaceae increases the number of species capable of causing experimental amber disease in grass grub." FEMS MICROBIOLOGY LETTERS, vol. 139, no. 2-3, 1996, pages 117-120, XP000998482 ISSN: 0378-1097 cited in the application * |
GRKOVIC STEVE ET AL: "Genes Essential for Amber Diseae in Grass Grubs Are Located on the Large Plasmid Found in Serratia entomophila and Serratia proteamaculans." APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 61, no. 6, 1995, pages 2218-2223, XP000994573 ISSN: 0099-2240 cited in the application * |
HURST MARK R H ET AL: "Plasmid-located pathogenicity determinants of Serratia entomophila, the causal agent of amber disease of grass grub, show similarity to the insecticidal toxins of Photorhabdus luminescens." JOURNAL OF BACTERIOLOGY, vol. 182, no. 18, September 2000 (2000-09), pages 5127-5138, XP002166799 ISSN: 0021-9193 * |
JACKSON T A ET AL: "PATHOGEN TO PRODUCT DEVELOPMENT OF SERRATIA-ENTOMOPHILA ENTEROBACTERIACEAE AS A COMMERCIAL BIOLOGICAL CONTROL AGENT FOR NEW ZEALAND GRASS GRUB COSTELYTRA-ZEALANDICA" JACKSON, T. A. AND T. R. GLARE (ED.). USE OF PATHOGENS IN SCARAB PEST, 1992, pages 191-198, XP000997900 0-946707-35-9. 1992 * |
NUNEZ-VALDEZ M E ET AL: "The amb2 locus from Serratia entomophila confers anti-feeding effect on larvae of Costelytra zealandica (Coleoptera: Scarabaeidae)" GENE,NL,ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, vol. 172, no. 1, 12 June 1996 (1996-06-12), pages 75-79, XP004042712 ISSN: 0378-1119 cited in the application * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102648281B (en) * | 2009-07-02 | 2017-04-05 | 阿森尼克斯公司 | 205 killing genes of AXMI and its using method |
CN102648281A (en) * | 2009-07-02 | 2012-08-22 | 阿森尼克斯公司 | AXMI-205 pesticidal gene and methods for its use |
US8575425B2 (en) | 2009-07-02 | 2013-11-05 | Athenix Corporation | AXMI-205 pesticidal gene and methods for its use |
US9221883B2 (en) | 2009-07-02 | 2015-12-29 | Athenix Corp. | AXMI-205 pesticidal gene and method for its use |
US9260487B2 (en) | 2009-07-02 | 2016-02-16 | Athenix Corp. | AXMI-205 pesticidal gene and method for its use |
WO2011002992A1 (en) * | 2009-07-02 | 2011-01-06 | Athenix Corp. | Axmi-205 pesticidal gene and methods for its use |
CN102899304A (en) * | 2011-07-26 | 2013-01-30 | 中国科学院上海生命科学研究院 | Protein having phytopathogen killing activity, and coding gene and application thereof |
US9862965B2 (en) | 2011-07-28 | 2018-01-09 | Athenix Corp. | AXMI205 variant proteins and methods of use |
US10875897B2 (en) | 2011-07-28 | 2020-12-29 | Basf Agricultural Solutions Seed, Us Llc | AXMI205 variant proteins and methods for their use |
US9394345B2 (en) | 2013-03-15 | 2016-07-19 | Pioneer Hi-Bred International, Inc. | PHI-4 polypeptides and methods for their use |
US9951348B2 (en) | 2013-03-15 | 2018-04-24 | Pioneer Hi-Bred International, Inc. | PHI-4 polypeptides and methods for their use |
US10023877B2 (en) | 2013-03-15 | 2018-07-17 | Pioneer Hi-Bred International, Inc. | PHI-4 polypeptides and methods for their use |
US10337026B2 (en) | 2013-03-15 | 2019-07-02 | Pioneer Hi-Bred International, Inc. | PHI-4 polypeptides and methods for their use |
US10577626B2 (en) | 2013-03-15 | 2020-03-03 | Pioneer Hi-Bred International, Inc. | PHI-4 polypeptides and methods for their use |
US11091771B2 (en) | 2013-03-15 | 2021-08-17 | Pioneer Hi-Bred International, Inc. | PHI-4 polypeptides and methods for their use |
US11180775B2 (en) | 2013-03-15 | 2021-11-23 | Pioneer Hi-Bred International, Inc. | PHI-4 polypeptides and methods for their use |
US11697821B2 (en) | 2013-03-15 | 2023-07-11 | Pioneer Hi-Bred International, Inc. | PHI-4 polypeptides and methods for their use |
Also Published As
Publication number | Publication date |
---|---|
WO2001016305A3 (en) | 2002-01-10 |
AU7461900A (en) | 2001-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OH et al. | The Hrp pathogenicity island of Erwinia amylovora and identification of three novel genes required for systemic infection | |
Preston et al. | Type III secretion in plant growth‐promoting Pseudomonas fluorescens SBW25 | |
DE69333980T2 (en) | TRIGGER OF SENSITIVITY REACTIONS IN PLANTS | |
Ruffner et al. | Oral insecticidal activity of plant‐associated pseudomonads | |
Ankenbauer et al. | FptA, the Fe (III)-pyochelin receptor of Pseudomonas aeruginosa: a phenolate siderophore receptor homologous to hydroxamate siderophore receptors | |
Gutterson | Microbial fungicides: recent approaches to elucidating mechanisms | |
US7696340B2 (en) | Nucleotide and amino acid sequences from Xenorhabdus and uses thereof | |
Tang et al. | Molecular cloning of protease gene (s) from Xanthomanas campestris pv. campestris: Expression in Escherichia coli and role in pathogenicity | |
RU2225114C2 (en) | Recombinant dna encoding protein that represents insecticide agent, insecticide agent (variants), strain of microorganism xenorhabdus nematophilus (variants), insecticide composition, method for control of insect-pests | |
BRPI0617496A2 (en) | bacillus thuringiensis isolated crystal insecticidal protein gene, recombinant DNA construct, microorganism and bacillus thuringiensis crystal insecticidal protein | |
CA2957803A1 (en) | Chromobacterium subtsugae genome | |
KR20010022649A (en) | Hypersensitive response elicitor from erwinia amylovora, its use, and encoding gene | |
CA2117270A1 (en) | Use of bacillus thuringiensis isolates for controlling pests in the family aphididae | |
Breil et al. | DNA sequence and mutational analysis of genes involved in the production and resistance of the antibiotic peptide trifolitoxin | |
Rohmer et al. | Nucleotide sequence, functional characterization and evolution of pFKN, a virulence plasmid in Pseudomonas syringae pathovar maculicola | |
Servant et al. | Production of Cry11A and Cry11Ba toxins in Bacillus sphaericus confers toxicity towards Aedes aegypti and resistant Culex populations | |
Benson et al. | An iron uptake operon required for proper nodule development in the Bradyrhizobium japonicum-soybean symbiosis | |
Ezra et al. | The dual function in virulence and host range restriction of a gene isolated from the pPATHEhg plasmid of Erwinia herbicola pv. gypsophilae | |
KR20230078719A (en) | Mu-diguetoxin-Dc1a mutant polypeptide for pest control | |
WO2001016305A2 (en) | Nucleotide sequences encoding an insectidal protein complex from serratia | |
US6841165B1 (en) | Insecticidal agents | |
NZ517478A (en) | Nucleotide sequences encoding an insecticidal protein complex from serratia | |
Kim et al. | Identification of genes for biosynthesis of antibacterial compound from Pseudomonas fluorescens Bl6, and its activity against Ralstonia solanacearum | |
US6071877A (en) | Polypeptides having a toxic activity against insects of the dipterae family | |
Traore | Characterization of type three effector genes of A. citrulli, the causal agent of bacterial fruit blotch of cucurbits |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 517478 Country of ref document: NZ |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
WWP | Wipo information: published in national office |
Ref document number: 517478 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 517478 Country of ref document: NZ |
|
NENP | Non-entry into the national phase |
Ref country code: JP |